You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...

Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...

Longer (8-14 days) antibiotic courses were not associated with increased antibiotic-associated adverse effects or benefits than shorter (3-7 days) antibiotic courses in community-dwelling older ...

An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...

More targeted antibiotics UVA's new approach was made possible by a herculean effort by Papin, Ph.D. student Emma Glass and their collaborators. Working with Andrew Warren, Ph.D., of UVA's ...

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

There is no link between antibiotic use and an increased risk for dementia or cognitive impairment in healthy adults aged ≥ 70 years, a new study suggests. However, investigators note that the ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the treatment of adults with complicated intra-abdominal infections (cIAI) with ...

Get Instant Summarized Text (Gist) Short-course antibiotic treatments for ventilator-associated pneumonia (VAP) are as effective as longer treatments in preventing death and recurrence, while ...